Abstract
‘Endometrial Carcinoma’: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make the corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM7 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the commoner non-carcinoma malignancies that are encountered at this site in diagnostic practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Al – Nafussi A. Uterine smooth muscle tumours: practical approach to diagnosis. Curr Diagn Pathol. 2004;10:140–56.
Allen DC. Histopathology reporting: guidelines for surgical cancer. 2nd ed. Springer: London; 2006.
Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol. 1995;26:1260–7.
Baak JPA, Mutter GL. EIN and WHO 94. J Clin Pathol. 2005;58:1–6.
Baker P, Oliva E. Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques. J Clin Pathol. 2007;60:235–43.
Burch DM, Tavassoli FA. Myxoid leiomyosarcoma of the uterus. Histopathology. 2011;59:1144–55.
Catasus L, Gallardo A, Prat J. Molecular genetics of endometrial carcinoma. Diagn Histopathol. 2009;15:554–9.
Chiang S, Oliva E. Recent developments in uterine mesenchymal neoplasms. Histopathology. 2013;62:124–37.
Clarke BA, Gilks CB. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type. J Clin Pathol. 2010;63:410–5.
Clarke B, McCluggage WG. Iatrogenic lesions and artefacts in gynaecological pathology. J Clin Pathol. 2009;62:104–12.
Darvishian F, Hummer AJ, Thaler HT, Bhargava R, Linkov I, Soslow RA. Serous endometrial cancers that mimic endometrial adenocarcinoma. Am J Surg Pathol. 2004;28:1568–78.
Ferguson SE, Tornos C, Hummer A, Barakat RR, Soslow RA. Prognostic features of surgical stage 1 uterine carcinosarcoma. Am J Surg Pathol. 2007;31:1653–61.
Folkins AK, Longacre TA. Hereditary gynaecological malignancies: advances in screening and treatment. Histopathology. 2013;62:2–30.
Fox H, Wells M, editors. Haines and Taylor. Obstetrical and gynaecological pathology. 5th ed. Edinburgh: Churchill Livingstone; 2003.
Garg K, Soslow RA. Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma. J Clin Pathol. 2009;62:679–84.
Grayson W, Cooper K. Application of immunohistochemistry in the evaluation of neoplastic epithelial lesions of the uterine cervix and endometrium. Curr Diagn Pathol. 2003;9:19–25.
Heatley MK. Dissection and reporting of the organs of the female genital tract. J Clin Pathol. 2008;61:241–57.
Herrington CS. Recent advances in molecular gynaecological pathology. Histopathology. 2009;55:243–9.
Hirschowitz L, Nucci M, Zaino RJ. Problematic issues in the staging of endometrial, cervical and vulval carcinomas. Histopathology. 2013;62:176–202.
Ismail SM. Gynaecological effects of Tamoxifen. J Clin Pathol. 1999;52:83–8.
Ismail SM. Histopathological challenges in the diagnosis of endometrial hyperplasia and carcinoma. Curr Diagn Pathol. 2006;12:312–24.
Loddenkemper C, Foss HD, Dallenbach FE, Stein H. Recent advances in the histopathology of stromal tumours of the endometrium. Curr Diagn Pathol. 2005;11:125–32.
Matias-Guiu X, Prat J. Molecular pathology of endometrial carcinoma. Histopathology. 2013;62:111–23.
McCluggage WG. My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol. 2006;59:801–12.
McCluggage WG. Problematic areas in the reporting of endometrial carcinomas in hysterectomy specimens. Diagn Histopathol. 2009;15:571–81.
McCluggage WG. Ten problematic issues identified by pathology review for multidisciplinary gynaecological oncology meetings. J Clin Pathol. 2012;65:293–301.
McCluggage WG, Hirschowitz L, Ganesan R, Kehoe S, Nordin A. Which staging system to use for gynaecological cancers: a survey with recommendations for practice in the UK. J Clin Pathol. 2010;63:768–70.
McCluggage WG, Connolly LE, McBride HA, Kalloger S, Gilks CB. HMGA2 is commonly expressed in uterine serous carcinomas and is a useful adjunct to diagnosis. Histopathology. 2012;60:547–53.
Nicolae A, Preda O, Nogales FF. Endometrial metaplasias and reactive changes: a spectrum of altered differentiation. J Clin Pathol. 2011;64:97–106.
Pecorelli S, FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. Int J Gynecol Obstet. 2009;105:103–4.
Prat J. FIGO Committee on Gynecologic Oncology. FIGO staging for uterine sarcomas. Int J Gynecol Obstet. 2009;104:177–8.
Robboy SJ, Bentley RC, Russell R, Anderson MC, Mutter GL, Prat J. Pathology of the female reproductive tract. 2nd ed. London: Churchill Livingstone Elsevier; 2009.
Saso S, Chatterjee J, Georgiou E, Ditri AM, Smith RJ, Ghaem-Maghami S. Endometrial cancer. BMJ. 2011;342:84–9.
Scurry J, Patel K, Wells M. Gross examination of uterine specimens. J Clin Pathol. 1993;46:388–93.
Silverberg SG. Protocol for the examination of specimens from patients with carcinomas of the endometrium. Arch Pathol Lab Med. 1999;123:28–32.
Silverberg SG, Kurman RJ. Tumors of the uterine corpus and gestational trophoblastic disease. Atlas of tumor pathology. 3rd series. Fascicle 3. Washington: AFIP; 1992.
Singh N. Synchronous tumours of the female genital tract. Histopathology. 2010;56:277–85.
Soslow RA. Uterine mesenchymal tumors: a review of selected topics. Diagn Histopathol. 2008;14:175–88.
Soslow RA. High-grade endometrial carcinomas – strategies for typing. Histopathology. 2013;62:89–110.
Stewart CJR, McCluggage WG. Epithelial-mesenchymal transition in carcinomas of the female genital tract. Histopathology. 2013;62:31–43.
Tavassoli F, Devilee P. WHO classification of tumours. Pathology and genetics. Tumours of the breast and female genital organs. Lyon: IARC Press; 2003.
The Royal College of Pathologists. Cancer Datasets (Vulval Neoplasms, Cervical Neoplasia, Endometrial Cancer, Uterine Sarcomas, Neoplasms of the Ovaries and Fallopian Tubes and Primary Carcinoma of the Peritoneum), and Tissue Pathways for Gynaecological Pathology. Accessed at http://www.rcpath.org/index.asp?PageID%20=254.
Wittekind C, International Union against Cancer, et al. TNM atlas: illustrated guide to the TNM/pTNM classification of malignant tumours. 5th ed. Berlin: Springer; 2005.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Allen, D.C. (2013). Endometrial Carcinoma. In: Histopathology Reporting. Springer, London. https://doi.org/10.1007/978-1-4471-5263-7_24
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5263-7_24
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5262-0
Online ISBN: 978-1-4471-5263-7
eBook Packages: MedicineMedicine (R0)